Corrigendum to "Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON)" [Respir. Med. 170 (Aug-Sep 2020) 106021]

Affiliations

• ¹ Universitätsklinikum Leipzig, Germany POIS Leipzig GbR, Leipzig, Germany. Electronic address: studien@pois-le.de.
• ² IKF Pneumologie Frankfurt, Clinical Research Centre Respiratory Diseases, Frankfurt, Germany.
• ³ Allergy and Respiratory Research Unit, Fundación CIDEA, Buenos Aires, Argentina.
• ⁴ Division of Pulmonology and UCT Lung Institute, University of Cape Town, Cape Town, South Africa.
• ⁵ Institut für Allergie- und Asthmaforschung Berlin, IAAB, Germany.
• ⁶ Novartis Pharma AG, Basel, Switzerland.
• ⁷ Novartis Healthcare Pvt. Ltd, Hyderabad, India.
• ⁸ Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States.